+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative pharmacology of mianserin its main metabolites and 6 aza mianserin



Comparative pharmacology of mianserin its main metabolites and 6 aza mianserin



Naunyn-Schmiedeberg's Archives of Pharmacology 319(1): 48-55



Mianserin, its main metabolites (8-hydroxymianserin, desmethylmianserin and mianserin-N-oxide) and a mianserin analog, 6-azamianserin (ORG 3770), were compared with regard to effects on monoamine uptake systems, .alpha.-adrenoceptors, rat exploratory activity and rat muricidal behavior. Mianserin and desmethylmianserin inhibited noradrenaline (nonepinephrine] uptake into synaptosomes (IC50 [median inhibitory concentration] 30 and 60 nM, respectively), whereas the other compounds were much less active. Synaptosomal serotonin uptake was only inhibited to a small extent by desmethylmianserin (IC50 6 .mu.M) and 8-hydroxymianserin (IC50 9 .mu.M). Dopamine uptake was not affected by any of the compounds tested. All compounds except mianserin-N-oxide blocked presynaptic .alpha.-receptors, as shown by the protentiation of high-K-induced release of noradrenaline from rat cerebral cortex slices. For mianserin and 6-azamianserin this blockade was stereoselective. Desmethylmianserin was less potent than mianserin. Binding of 3H-dihydroergocryptine to rat cerebral cortex membranes was inhibited by all compounds except mianserin-N-oxide. Desmethylmianserin was less active than mianserin. None of the compounds appeared to block presynaptic .alpha.-receptors in preference to postsynaptic .alpha.-adrenoceptors. The compounds studied failed to antagonize clonidine-induced sedation in the open field. Clonidine-induced diuresis was stereoselectively inhibited by 6-azamianserin, but the involvement of .alpha.2-receptors in this phenomenon is not firmly established. Antihistamine properties as determined by 3H-mepyramine binding to rat brain membranes were most pronounced for 6-azamianserin. Mianserin was slightly less potent and desmethylmianserin and 8-hydroxymianserin were 10 and 30 times less potent than mianserin, respectively. Muricidal behavior was inhibited by all compounds except mianserin-N-oxide. The least active was 8-hydroxymianeserin. In contrast to mianserin and desmethylmianserin, the blockade of muricidal behavior by 6-azamianserin was nonspecific, since it occurrred at doses which caused a strong depression of rat open field behavior. Mianserin was less sedative than 6-azamianserin, whereas the metabolites showed no sedative effects at doses up to 32 mg/kg in the open field The main metabolites of mianserin possess pharmacological properties which may add to the therapeutic potential of mianserin. Clinical testing of 8-hydroxymianserin and 6-azamianserin may indicate whether the antidepressant effect of mianserin is solely based upon its interaction with presynaptic .alpha.-adrenoceptors or is due to a concomitant blockade of noradrenaline reuptake.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 004997523

Download citation: RISBibTeXText

PMID: 6287300


Related references

Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline. Advances in Biochemical Psychopharmacology 32: 195-212, 1982

Subjective side effects of mianserin in relation to plasma concentrations of mianserin and demethylmianserin. Therapeutic Drug Monitoring 14(3): 190-193, 1992

Subjective Side Effects of Mianserin in Relation to Plasma Concentrations of Mianserin and Desmethylmianserin. Therapeutic Drug Monitoring 14(3): 190-193, 1992

Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients. Chirality 6(7): 555-563, 1994

Prediction of Plasma Concentrations of Mianserin and Desmethylmianserin at Steady State from Those After an Initial Dose of Mianserin. Therapeutic Drug Monitoring 15(2): 118-121, 1993

Prediction of plasma concentrations of mianserin and demethylmianserin at steady state from those after an initial dose of mianserin. Therapeutic Drug Monitoring 15(2): 118-121, 1993

The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients. Journal of Clinical Psychopharmacology 17(6): 467-471, 1997

Cardiovascular tolerance of mianserin and interactions of mianserin with other drugs. Acta Psychiatrica Belgica 78(5): 787-797, 1978

Differential mode of antagonism of 5 hydroxy tryptamine induced pressor effects by dextro mianserin and levo mianserin in pithed rats. Journal of Pharmacy & Pharmacology 35(8): 534-535, 1983

The pharmacology of mianserin--an update. British Journal of Clinical Pharmacology 15 Suppl 2: 263s-268s, 1983

Mianserin metabolites. British Journal of Clinical Pharmacology 16(2): 201-203, 1983

The pharmacology of mianserin (Org. GB 94) Leviron, a really different antidepressant. Acta Psychiatrica Belgica 78(5): 756-769, 1978

Behavioral pharmacology of mianserin hydrochloride, a new antidepressant. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(6): 533-547, 1980

Workshop on the clinical pharmacology and efficacy of mianserin. British Journal of Clinical Pharmacology 5 Suppl 1: 91s-99s, 1978

Mianserin: pharmacology and clinical aspects of an effective antidepressive agents. Fortschritte der Medizin 111(31): 497-500, 1993